CDKN2A and cancer: The absence of a significant p16 expression in most normal tissues in combination with a high frequency of p16 overexpression in cancers of all types demonstrates a significant role of p16 in cancer biology and suggest a general utility of p16 immunohistochemistry as a potential aid to diagnose malignancy.